tirzepatide heart failure UC Irvine researchers project cardiac benefits from weight-loss medication 💊 New research in obesity

doi: 10.2196/52987

2.5 M semaglutide with or without 25 M icodec)

Mochi will work with you to make sure you have medications that can cover you in the interim while we are waiting for your insurance to provide final approval

[DOI] [PubMed] [Google Scholar] 693.Goke R., Fehmann H.C., Linn T., Schmidt H., Krause M., Eng J., et al

One in ten British adults used or interested in GLP-1 medications for weight loss owenhaskins Jan 8 4 min read In 2025, approximately 4.9 million British adults almost one in ten are estimated to have recently used, or expressed interest in using, glucagon-like peptide-1 (GLP-1) or dual GLP-1/glucose-dependent insulinotropic polypeptide (GIP) receptor agonist medications to support weight loss

Although some people could make some rapid improvements, others may need more time to achieve significant weight loss